Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Troglitazone price-listed in Japan

Jan. 20, 1997

New amylin antagonists from Amylin

Jan. 20, 1997

More antiobesity proteins in the pipeline at Lilly

Jan. 20, 1997

New ACAT inhibitors claimed by DuPont Merck

Jan. 20, 1997

MacroChem to begin clinical trials of SEPA-testosterone

Jan. 17, 1997

AI-401 clinical trial program updated

Jan. 17, 1997

Terrapin, Sanwa establish diabetes R&D collaboration

Jan. 17, 1997

Cortecs signs first European licensing agreement for oral calcitonin

Jan. 17, 1997

Pfizer reports new GH stimulants

Jan. 17, 1997

Pfizer investigates beta-adrenoceptor agonists

Jan. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...